These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 26181622)
1. Synthesis and pharmaceutical properties of N-acyloxymethyl prodrugs of Allop with potential anti-trypanosomal activity. Gualdesi MS; Ortiz CS; Raviolo MA Drug Dev Ind Pharm; 2016; 42(4):602-10. PubMed ID: 26181622 [TBL] [Abstract][Full Text] [Related]
2. Synthesis, physicochemical properties of allopurinol derivatives and their biological activity against Trypanosoma cruzi. Raviolo MA; Solana ME; Novoa MM; Gualdesi MS; Alba-Soto CD; Briñón MC Eur J Med Chem; 2013 Nov; 69():455-64. PubMed ID: 24090917 [TBL] [Abstract][Full Text] [Related]
3. Synthesis and in vitro evaluation of potential antichagasic dipeptide prodrugs of primaquine. Chung MC; Gonçalves MF; Colli W; Ferreira EI; Miranda MT J Pharm Sci; 1997 Oct; 86(10):1127-31. PubMed ID: 9344169 [TBL] [Abstract][Full Text] [Related]
4. Synthesis and in vitro evaluation of potential antichagasic hydroxymethylnitrofurazone (NFOH-121): a new nitrofurazone prodrug. Chung MC; Güido RV; Martinelli TF; Gonçalves MF; Polli MC; Botelho KC; Varanda EA; Colli W; Miranda MT; Ferreira EI Bioorg Med Chem; 2003 Nov; 11(22):4779-83. PubMed ID: 14556793 [TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological evaluation of quinones derived from natural product komaroviquinone as anti-Trypanosoma cruzi agents. Suto Y; Nakajima-Shimada J; Yamagiwa N; Onizuka Y; Iwasaki G Bioorg Med Chem Lett; 2015 Aug; 25(15):2967-71. PubMed ID: 26037321 [TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, and evaluation of potential prodrugs of DFMO for reductive activation. Yang Y; Voak A; Wilkinson SR; Hu L Bioorg Med Chem Lett; 2012 Nov; 22(21):6583-6. PubMed ID: 23031595 [TBL] [Abstract][Full Text] [Related]
8. 3-Nitrotriazole-based piperazides as potent antitrypanosomal agents. Papadopoulou MV; Bloomer WD; Rosenzweig HS; O'Shea IP; Wilkinson SR; Kaiser M Eur J Med Chem; 2015 Oct; 103():325-34. PubMed ID: 26363868 [TBL] [Abstract][Full Text] [Related]
9. 2-Pyridyl thiazoles as novel anti-Trypanosoma cruzi agents: structural design, synthesis and pharmacological evaluation. Cardoso MV; de Siqueira LR; da Silva EB; Costa LB; Hernandes MZ; Rabello MM; Ferreira RS; da Cruz LF; Moreira DR; Pereira VR; de Castro MC; Bernhardt PV; Leite AC Eur J Med Chem; 2014 Oct; 86():48-59. PubMed ID: 25147146 [TBL] [Abstract][Full Text] [Related]
10. Synthesis and anti-trypanosomal activity of novel 5-nitro-2-furaldehyde and 5-nitrothiophene-2-carboxaldehyde semicarbazone derivatives. Cerecetto H; Di Maio R; Ibarruri G; Seoane G; Denicola A; Peluffo G; Quijano C; Paulino M Farmaco; 1998 Feb; 53(2):89-94. PubMed ID: 9604315 [TBL] [Abstract][Full Text] [Related]
11. Synthesis and in vitro trypanocidal activity of some novel iron chelating agents. Singh PK; Jones MM; Lane JE; Nesset A; Zimmerman LJ; Ribeiro-Rodrigues R; Richter A; Stenger MR; Carter CE Arzneimittelforschung; 1997 Mar; 47(3):311-5. PubMed ID: 9105552 [TBL] [Abstract][Full Text] [Related]
12. Synthesis, in vitro antitrypanosomal and antibacterial activity of phenoxy, phenylthio or benzyloxy substituted quinolones. Ma X; Zhou W; Brun R Bioorg Med Chem Lett; 2009 Feb; 19(3):986-9. PubMed ID: 19095449 [TBL] [Abstract][Full Text] [Related]
13. Synthesis of naphthofuranquinones with activity against Trypanosoma cruzi. Silva RS; Costa EM; Trindade UL; Teixeira DV; Pinto Mde C; Santos GL; Malta VR; De Simone CA; Pinto AV; de Castro SL Eur J Med Chem; 2006 Apr; 41(4):526-30. PubMed ID: 16500733 [TBL] [Abstract][Full Text] [Related]
14. Synthesis and evaluation of antioxidant and trypanocidal properties of a selected series of coumarin derivatives. Guíñez RF; Matos MJ; Vazquez-Rodriguez S; Santana L; Uriarte E; Olea-Azar C; Maya JD Future Med Chem; 2013 Oct; 5(16):1911-22. PubMed ID: 24175743 [TBL] [Abstract][Full Text] [Related]
15. Optimization of antitrypanosomatid agents: identification of nonmutagenic drug candidates with in vivo activity. Álvarez G; Varela J; Márquez P; Gabay M; Arias Rivas CE; Cuchilla K; Echeverría GA; Piro OE; Chorilli M; Leal SM; Escobar P; Serna E; Torres S; Yaluff G; Vera de Bilbao NI; González M; Cerecetto H J Med Chem; 2014 May; 57(10):3984-99. PubMed ID: 24749923 [TBL] [Abstract][Full Text] [Related]
16. Design, synthesis and biological evaluation of new potent 5-nitrofuryl derivatives as anti-Trypanosoma cruzi agents. Studies of trypanothione binding site of trypanothione reductase as target for rational design. Aguirre G; Cabrera E; Cerecetto H; Di Maio R; González M; Seoane G; Duffaut A; Denicola A; Gil MJ; Martínez-Merino V Eur J Med Chem; 2004 May; 39(5):421-31. PubMed ID: 15110968 [TBL] [Abstract][Full Text] [Related]
17. Naphthoquinoidal [1,2,3]-triazole, a new structural moiety active against Trypanosoma cruzi. da Silva EN; Menna-Barreto RF; Pinto Mdo C; Silva RS; Teixeira DV; de Souza MC; De Simone CA; De Castro SL; Ferreira VF; Pinto AV Eur J Med Chem; 2008 Aug; 43(8):1774-80. PubMed ID: 18045742 [TBL] [Abstract][Full Text] [Related]
18. Discovery of potent nitrotriazole-based antitrypanosomal agents: In vitro and in vivo evaluation. Papadopoulou MV; Bloomer WD; Rosenzweig HS; O'Shea IP; Wilkinson SR; Kaiser M; Chatelain E; Ioset JR Bioorg Med Chem; 2015 Oct; 23(19):6467-76. PubMed ID: 26344593 [TBL] [Abstract][Full Text] [Related]
19. Synthesis and tripanocidal activity of ferrocenyl and benzyl diamines against Trypanosoma brucei and Trypanosoma cruzi. Velásquez AM; Francisco AI; Kohatsu AA; Silva FA; Rodrigues DF; Teixeira RG; Chiari BG; de Almeida MG; Isaac VL; Vargas MD; Cicarelli RM Bioorg Med Chem Lett; 2014 Apr; 24(7):1707-10. PubMed ID: 24630563 [TBL] [Abstract][Full Text] [Related]